@article{16e73a08c2ec4f06aa475f4b449bb54a,
title = "The clinician as investigator: Participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design",
keywords = "Biological Markers, Clinical Medicine, Clinical Trials as Topic, Double-Blind Method, Endpoint Determination, Evidence-Based Medicine, Follow-Up Studies, Humans, Randomized Controlled Trials as Topic, Registries, Research Design, Research Personnel, Sample Size, Single-Blind Method",
author = "Lader, \{Ellis W.\} and Cannon, \{Christopher P.\} and Ohman, \{E. Magnus\} and Newby, \{L. Kristin\} and Sulmasy, \{Daniel P.\} and Barst, \{Robyn J.\} and Fair, \{Joan M.\} and Marcus Flather and Freedman, \{Jane E.\} and Frye, \{Robert L.\} and Hand, \{Mary M.\} and Jesse, \{Robert L.\} and \{Van de Werf\}, Frans and Fernando Costa",
year = "2004",
month = jun,
day = "1",
doi = "10.1161/01.CIR.0000128807.57602.61",
language = "English",
volume = "109",
pages = "e302--e304",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "21",
}